These final results, together with a prior report displaying that a little-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,two support the idea of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-relevant Issues.By ticking this box and distributing t